Diversity of vacA and cagA genes of Helicobacter pylori in Japanese children

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 20, Issue 1, 2004, Pages 7-12

  Azuma, T ^a   Kato, S ^b   Zhou, W ^a,c   Yamazaki, S ^a   Yamakawa, A ^a   Ohtani, M ^a   Fujiwara, S ^d   Minoura, T ^b   Iinuma, K ^b   Kato, T ^e  

^a UNIVERSITY OF FUKUI   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c ZHEJIANG UNIVERSITY   (China)

^d MIYAGI UNIVERSITY   (Japan)

^e FUKUI PREFECTURAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; VACUOLATING TOXIN;

BACTERIUM CULTURE; BACTERIUM ISOLATION; CHRONIC GASTRITIS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; JAPAN; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIC ULCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; SEQUENCE ANALYSIS; TRAVEL; TREATMENT OUTCOME;

EID: 4344594557     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2004.01980.x     Document Type: Conference Paper

References (37)

1. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273-5.
2. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH consensus development panel on Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-9.
3. Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437-42.
4. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 11127-31.
5. Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity. Proc Natl Acad Sci USA 1993; 90: 5791-5.
6. Cover TL, Blaser MJ. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem 1992; 267: 10570-5.
7. Cover TL. The vacuolating cytotoxin of Helicobacter pylori. Mol Microbiol 1996; 20: 241-6.
8. Tee W, Lambert JR, Dwyer B. Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases. J Clin Microbiol 1995; 33: 1203-5.
9. Hirai M, Azuma T, Ito S, Kato T, Kohli Y, Fujiki N. High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric carcinoma patients. Int J Cancer 1994; 56: 56-60.
10. van Doorn LJ, Figueiredo C, Sanna R, et al. Clinical relevance of cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 1998; 115: 58-66.
11. Atherton JC, Cao P, Peek RM, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270: 17771-7.
12. Xiang Z, Censini S, Bsyeli PF, et al. Analysis of expression of cagA and vacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that cagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995; 63: 94-8.
13. van Doom LJ, Figueiredo C, Sanna R, et al. Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol 1998; 36: 2597-603.
14. Pan Z, Berg DE, van der Hulst RWM, et al. Prevalence of vacuolating cytotoxin production and distribution of distinct vacA alleles in Helicobacter pylori from China. J Infect Dis 1998; 178: 220-6.
15. Censini S, Lange C, Xiang Z, et al. Cag. a pathogenicity island of Helicobacter pylori, encodes type I-specific and diseaseassociated virulence factors. Proc Natl Acad Sci USA 1996; 93: 14648-53.
16. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 1999; 284: 1328-33.
17. Asahi M, Azuma T, Ito S, et al. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med 2000; 191: 593-602.
18. Stein M, Rappuoli R, Covacci A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci USA 2000; 97: 1263-8.
19. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci USA 1999; 96: 14559-64.
20. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000; 287: 1497-500.
21. Higashi H, Tsutsumi R, Muto S, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002; 295: 683-6.
22. Feng G, Hui C, Pawson T. SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. Science 1993; 259: 1607-11.
23. Yamaoka Y, Kodama T, Kashima K, Graham DY, Sepulveda AR. Variants of the 3′ region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol 1998; 36: 2258-63.
24. Yamaoka Y, El-Zimaity HM, Gutierrez O, et al. Relationship between the cagA-3′ repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology 1999; 117: 342-9.
25. Higashi H, Tsutsumi R, Fujita A, et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci USA 2002; 99: 14428-33.
26. Azuma T, Yamakawa A, Yamazaki S, et al. Correlation between variation of the 3′ region of the cagA gene in Helicobacter pylon and disease outcome in Japan. J Infect Dis 2002; 186: 1621-30.
27. Ito Y, Azuma T, Ito S, et al. Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol 1997; 35: 1710-4.
28. Ito Y, Azuma T, Ito S, et al. Full-Length sequence analysis of the vaca gene from cytotoxic and noncytotoxic Helicobacter pylori. J Infect Dis 1998; 178: 1391-8.
29. Van Doorn LJ, Figueiredo C, Megraud F, et al. Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology 1999; 116: 823-30.
30. Kato S, Sugiyama T, Kudo M, et al. CagA antibodies in Japanese children with nodular gastritis or peptic ulcer disease. J Clin Microbiol 2000; 38: 68-70.
31. Achtman M, Azuma T, Berg DE, et al. Recombination and clonal groupings within Helicobacter pylori from different geographical regions. Mol Microbiol 1999; 32: 459-70.
32. Freeman R, Plutzky J, Neel BG. Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew. Proc Natl Acad Sci USA 1992; 89: 11239-43.
33. Yu D, Qu C, Henegariu O, Lu X, Feng G. Protein-tyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion. J Biol Chem 1998; 273: 21125-31.
34. Kato S, Ozawa K, Okuda M, et al. Accuracy of the stool antigen test for the diagnosis of childhood Helicobacter pylori infection: a multicenter Japanese study. Am J Gastroenterol 2003; 98: 296-300.
35. Ko JS, Seo JK. cag pathogenicity island of Helicobacter pylori in Korean children. Helicobacter 2002; 7: 232-6.
36. Falush D, Wirth T, Linz B, et al. Traces of human migrations in Helicobacter pylori populations. Science 2003; 299: 1582-5.
37. Zhou W, Yamazaki S, Yamakawa A, et al. The diversity of vacA and cagA genes of Helicobacter pylori in East Asia. FEMS Immunol Med Microbiol 2004; 40: 81-7.